Pharmaxis Ltd
Pharmaxis Ltd PXS.AX Peers
See (PXS.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PXS.AX | A$0.03 | +3.70% | 20.2M | -1.40 | -A$0.02 | N/A |
| CAU.AX | A$0.54 | N/A | 300.5M | -16.88 | -A$0.03 | N/A |
| AFP.AX | A$2.48 | +1.22% | 260.1M | 24.80 | A$0.10 | +0.59% |
| PBP.AX | A$2.98 | -0.33% | 242.3M | 29.80 | A$0.10 | +1.26% |
| LV1.AX | A$0.92 | N/A | 144.1M | 3.05 | A$0.30 | N/A |
| VLS.AX | A$1.82 | +0.28% | 99.1M | 11.38 | A$0.16 | +5.49% |
| MVP.AX | A$0.65 | +1.56% | 73.2M | -1.91 | -A$0.34 | N/A |
| IHL.AX | A$0.04 | -10.87% | 65.1M | -0.03 | -A$1.30 | N/A |
| ANP.AX | A$0.06 | -4.92% | 52.3M | -2.90 | -A$0.02 | N/A |
| VIT.AX | A$0.07 | -1.47% | 44.4M | 6.70 | A$0.01 | N/A |
Stock Comparison
PXS.AX vs CAU.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, CAU.AX has a market cap of 300.5M. Regarding current trading prices, PXS.AX is priced at A$0.03, while CAU.AX trades at A$0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas CAU.AX's P/E ratio is -16.88. In terms of profitability, PXS.AX's ROE is -1.43%, compared to CAU.AX's ROE of +0.34%. Regarding short-term risk, PXS.AX is less volatile compared to CAU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs AFP.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, AFP.AX has a market cap of 260.1M. Regarding current trading prices, PXS.AX is priced at A$0.03, while AFP.AX trades at A$2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas AFP.AX's P/E ratio is 24.80. In terms of profitability, PXS.AX's ROE is -1.43%, compared to AFP.AX's ROE of +0.14%. Regarding short-term risk, PXS.AX is less volatile compared to AFP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs PBP.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, PBP.AX has a market cap of 242.3M. Regarding current trading prices, PXS.AX is priced at A$0.03, while PBP.AX trades at A$2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas PBP.AX's P/E ratio is 29.80. In terms of profitability, PXS.AX's ROE is -1.43%, compared to PBP.AX's ROE of +0.13%. Regarding short-term risk, PXS.AX is less volatile compared to PBP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs LV1.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, LV1.AX has a market cap of 144.1M. Regarding current trading prices, PXS.AX is priced at A$0.03, while LV1.AX trades at A$0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas LV1.AX's P/E ratio is 3.05. In terms of profitability, PXS.AX's ROE is -1.43%, compared to LV1.AX's ROE of -4.96%. Regarding short-term risk, PXS.AX is less volatile compared to LV1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs VLS.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, VLS.AX has a market cap of 99.1M. Regarding current trading prices, PXS.AX is priced at A$0.03, while VLS.AX trades at A$1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas VLS.AX's P/E ratio is 11.38. In terms of profitability, PXS.AX's ROE is -1.43%, compared to VLS.AX's ROE of +0.17%. Regarding short-term risk, PXS.AX and VLS.AX have similar daily volatility (0.00).
PXS.AX vs MVP.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, MVP.AX has a market cap of 73.2M. Regarding current trading prices, PXS.AX is priced at A$0.03, while MVP.AX trades at A$0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas MVP.AX's P/E ratio is -1.91. In terms of profitability, PXS.AX's ROE is -1.43%, compared to MVP.AX's ROE of -0.59%. Regarding short-term risk, PXS.AX is less volatile compared to MVP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs IHL.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, IHL.AX has a market cap of 65.1M. Regarding current trading prices, PXS.AX is priced at A$0.03, while IHL.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas IHL.AX's P/E ratio is -0.03. In terms of profitability, PXS.AX's ROE is -1.43%, compared to IHL.AX's ROE of -0.33%. Regarding short-term risk, PXS.AX is less volatile compared to IHL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs ANP.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, ANP.AX has a market cap of 52.3M. Regarding current trading prices, PXS.AX is priced at A$0.03, while ANP.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas ANP.AX's P/E ratio is -2.90. In terms of profitability, PXS.AX's ROE is -1.43%, compared to ANP.AX's ROE of -0.73%. Regarding short-term risk, PXS.AX is less volatile compared to ANP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs VIT.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, VIT.AX has a market cap of 44.4M. Regarding current trading prices, PXS.AX is priced at A$0.03, while VIT.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas VIT.AX's P/E ratio is 6.70. In terms of profitability, PXS.AX's ROE is -1.43%, compared to VIT.AX's ROE of +0.05%. Regarding short-term risk, PXS.AX is less volatile compared to VIT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs IDT.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, IDT.AX has a market cap of 44.3M. Regarding current trading prices, PXS.AX is priced at A$0.03, while IDT.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas IDT.AX's P/E ratio is -10.50. In terms of profitability, PXS.AX's ROE is -1.43%, compared to IDT.AX's ROE of -0.19%. Regarding short-term risk, PXS.AX and IDT.AX have similar daily volatility (0.00).
PXS.AX vs LGP.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, LGP.AX has a market cap of 31.9M. Regarding current trading prices, PXS.AX is priced at A$0.03, while LGP.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas LGP.AX's P/E ratio is -3.50. In terms of profitability, PXS.AX's ROE is -1.43%, compared to LGP.AX's ROE of -0.12%. Regarding short-term risk, PXS.AX is less volatile compared to LGP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs CPH.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, CPH.AX has a market cap of 23.1M. Regarding current trading prices, PXS.AX is priced at A$0.03, while CPH.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas CPH.AX's P/E ratio is -0.45. In terms of profitability, PXS.AX's ROE is -1.43%, compared to CPH.AX's ROE of -1.31%. Regarding short-term risk, PXS.AX and CPH.AX have similar daily volatility (0.00).
PXS.AX vs NXS.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, NXS.AX has a market cap of 20.5M. Regarding current trading prices, PXS.AX is priced at A$0.03, while NXS.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas NXS.AX's P/E ratio is -1.17. In terms of profitability, PXS.AX's ROE is -1.43%, compared to NXS.AX's ROE of -2.01%. Regarding short-term risk, PXS.AX is less volatile compared to NXS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs AGH.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, AGH.AX has a market cap of 19.7M. Regarding current trading prices, PXS.AX is priced at A$0.03, while AGH.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas AGH.AX's P/E ratio is -0.60. In terms of profitability, PXS.AX's ROE is -1.43%, compared to AGH.AX's ROE of -51.14%. Regarding short-term risk, PXS.AX is less volatile compared to AGH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs MXC.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, MXC.AX has a market cap of 18.4M. Regarding current trading prices, PXS.AX is priced at A$0.03, while MXC.AX trades at A$0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas MXC.AX's P/E ratio is -0.13. In terms of profitability, PXS.AX's ROE is -1.43%, compared to MXC.AX's ROE of +26.60%. Regarding short-term risk, PXS.AX is less volatile compared to MXC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs AC8.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, AC8.AX has a market cap of 17.6M. Regarding current trading prices, PXS.AX is priced at A$0.03, while AC8.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas AC8.AX's P/E ratio is -0.67. In terms of profitability, PXS.AX's ROE is -1.43%, compared to AC8.AX's ROE of -0.61%. Regarding short-term risk, PXS.AX is less volatile compared to AC8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs ECS.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, ECS.AX has a market cap of 13M. Regarding current trading prices, PXS.AX is priced at A$0.03, while ECS.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas ECS.AX's P/E ratio is N/A. In terms of profitability, PXS.AX's ROE is -1.43%, compared to ECS.AX's ROE of -0.05%. Regarding short-term risk, PXS.AX and ECS.AX have similar daily volatility (0.00).
PXS.AX vs PER.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, PER.AX has a market cap of 10.9M. Regarding current trading prices, PXS.AX is priced at A$0.03, while PER.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas PER.AX's P/E ratio is -0.50. In terms of profitability, PXS.AX's ROE is -1.43%, compared to PER.AX's ROE of -1.23%. Regarding short-term risk, PXS.AX and PER.AX have similar daily volatility (0.00).
PXS.AX vs HGV.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, HGV.AX has a market cap of 10.1M. Regarding current trading prices, PXS.AX is priced at A$0.03, while HGV.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas HGV.AX's P/E ratio is -2.40. In terms of profitability, PXS.AX's ROE is -1.43%, compared to HGV.AX's ROE of -0.01%. Regarding short-term risk, PXS.AX is less volatile compared to HGV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs IVX.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, IVX.AX has a market cap of 9.3M. Regarding current trading prices, PXS.AX is priced at A$0.03, while IVX.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas IVX.AX's P/E ratio is -1.00. In terms of profitability, PXS.AX's ROE is -1.43%, compared to IVX.AX's ROE of -0.49%. Regarding short-term risk, PXS.AX is less volatile compared to IVX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs CAN.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, CAN.AX has a market cap of 8.7M. Regarding current trading prices, PXS.AX is priced at A$0.03, while CAN.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas CAN.AX's P/E ratio is -0.14. In terms of profitability, PXS.AX's ROE is -1.43%, compared to CAN.AX's ROE of -4.70%. Regarding short-term risk, PXS.AX is less volatile compared to CAN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs EPN.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, EPN.AX has a market cap of 8.3M. Regarding current trading prices, PXS.AX is priced at A$0.03, while EPN.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas EPN.AX's P/E ratio is -2.40. In terms of profitability, PXS.AX's ROE is -1.43%, compared to EPN.AX's ROE of -0.13%. Regarding short-term risk, PXS.AX is less volatile compared to EPN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs EOF.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, EOF.AX has a market cap of 7.3M. Regarding current trading prices, PXS.AX is priced at A$0.03, while EOF.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas EOF.AX's P/E ratio is -0.50. In terms of profitability, PXS.AX's ROE is -1.43%, compared to EOF.AX's ROE of -0.51%. Regarding short-term risk, PXS.AX is less volatile compared to EOF.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs CGB.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, CGB.AX has a market cap of 5.6M. Regarding current trading prices, PXS.AX is priced at A$0.03, while CGB.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas CGB.AX's P/E ratio is -0.70. In terms of profitability, PXS.AX's ROE is -1.43%, compared to CGB.AX's ROE of +0.00%. Regarding short-term risk, PXS.AX and CGB.AX have similar daily volatility (0.00).
PXS.AX vs BOD.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, BOD.AX has a market cap of 4.3M. Regarding current trading prices, PXS.AX is priced at A$0.03, while BOD.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas BOD.AX's P/E ratio is -0.40. In terms of profitability, PXS.AX's ROE is -1.43%, compared to BOD.AX's ROE of +0.66%. Regarding short-term risk, PXS.AX is less volatile compared to BOD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs SCU.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, SCU.AX has a market cap of 3.9M. Regarding current trading prices, PXS.AX is priced at A$0.03, while SCU.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas SCU.AX's P/E ratio is N/A. In terms of profitability, PXS.AX's ROE is -1.43%, compared to SCU.AX's ROE of -0.66%. Regarding short-term risk, PXS.AX is less volatile compared to SCU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs EXL.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, EXL.AX has a market cap of 3.1M. Regarding current trading prices, PXS.AX is priced at A$0.03, while EXL.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas EXL.AX's P/E ratio is -1.40. In terms of profitability, PXS.AX's ROE is -1.43%, compared to EXL.AX's ROE of -0.20%. Regarding short-term risk, PXS.AX is less volatile compared to EXL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for PXS.AX.
PXS.AX vs TSN.AX Comparison
PXS.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PXS.AX stands at 20.2M. In comparison, TSN.AX has a market cap of 1.4M. Regarding current trading prices, PXS.AX is priced at A$0.03, while TSN.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PXS.AX currently has a P/E ratio of -1.40, whereas TSN.AX's P/E ratio is -0.33. In terms of profitability, PXS.AX's ROE is -1.43%, compared to TSN.AX's ROE of -0.97%. Regarding short-term risk, PXS.AX and TSN.AX have similar daily volatility (0.00).